Reflections on the Global Pandemic of COVID-19 and the Response Strategies

LU Quan; LU Quan

Paper Submission

Reflections on the Global Pandemic of COVID-19 and the Response Strategies

LU Quan

Abstract

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, posing great challenges to the public health system and threatening the health and survival of humans. The outbreak of COVID-19 leaves us with much to reflect on and calls on our attention to respiratory infectious diseases, especially new outbreaks of respiratory infectious diseases that are zoonotic. The importance of identifying viral pathogens should be highlighted because it is related to the prevention and treatment strategy of childhood pneumonia. Due to the highly infectious nature of COVID-19, the rapid mutation of the virus, and the lack of specific drugs, vaccines are currently the most effective means of prevention, and a global immune barrier must be established as soon as possible.

Keywords: Pneumonia, SARS-CoV-2, Coping strategy, Reflections

Full Text:

PDF

References

PETERSEN E， KOOPMANS M， GO U， et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis，2020，20(9): e238–e244.

JAIN S， WILLIAMS D J， ARNOLD S R， et al. Community-acquired pneumonia requiring hospitalization among U. S. children. N Engl J Med， 2015，372(9): 835–845.

The Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: The PERCH multi-country case-control study. Lancet，2019，394(10200): 757–779.

BAYHAM J， FENICHEL E P. Impact of school closures for COVID-19 on the US health-care workforce and net mortality: A modelling study. Lancet Public Health，2020，5(5): e271–e278[2021-06-01]. https://doi.org/10. 1016/S2468-2667(20)30082-7.

HOFFMANN M， KLEINE-WEBER H， SCHROEDER S， et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell，2020，181(2): 271–280.e8.

SPINELLI M A， GLIDDEN D V， GENNATAS E D， et al. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. Lancet Infect Dis，2021，21(9): e296–e301.

WHO. Tracking SARS-CoV-2 variants. (2021-05-31) [2021-06-01]. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/COVID-19.